Results 231 to 240 of about 115,987 (377)

Sita‐ and saxagliptin use and autoantibodies to autoimmune bullous diseases: A cross‐sectional study

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Sören Dräger   +8 more
wiley   +1 more source

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon‐like peptide‐1 and glucagon receptor in healthy subjects

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 579-588, February 2026.
Aims Glucagon‐like peptide‐1 (GLP‐1) and glucagon dual receptor agonists are in clinical development for a range of metabolic conditions, including type 2 diabetes and obesity. The cardiovascular actions at these receptors are well studied, but less is known about their combination.
James Goodman   +13 more
wiley   +1 more source

Associations of Diabetes, Smoking, and Metabolic Factors With the Risk of Breast and Prostate Cancers: A Population‐Based Retrospective Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Background Previous studies reported an inverse association between diabetes and prostate cancer. Moreover, the associations of smoking with breast and prostate cancers remain inconclusive. This study aims to investigate whether diabetes, smoking, or metabolic factors are associated with female breast and prostate cancers incidence, and ...
Sarah Tsz Yui Yau   +4 more
wiley   +1 more source

Elevated circulating dipeptidyl peptidase 3 (cDPP3) as a predictor of postoperative complications in esophagectomy patients. [PDF]

open access: yesLangenbecks Arch Surg
Nottberg VI   +9 more
europepmc   +1 more source

Vildagliptin and Omarigliptin Differentially Bind to DPP‐4 Homodimers and Modulate Osteoclast‐Mediated Bone Resorption

open access: yesComprehensive Physiology, Volume 16, Issue 1, February 2026.
Vildagliptin and omarigliptin, dipeptidyl peptidase‐4 (DPP‐4) inhibitors, have differential effects on bone cells. Although vildagliptin improved the bone microstructure of high‐fat diet‐fed rats, it was unable to downregulate osteoclastogenesis or the expression of key osteoclast transcripts.
Ratchaneevan Aeimlapa   +11 more
wiley   +1 more source

Topical administration of dipeptidyl peptidase IV (DPP-IV) inhibitors prevents retinal neurodegeneration in experimental diabetes

open access: green, 2017
Cristina Hernández   +7 more
openalex   +1 more source

Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554

open access: green, 2011
Hironobu Maezaki   +18 more
openalex   +1 more source

Home - About - Disclaimer - Privacy